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Dissection of tumour and host cells from target organs of metastasis for
testing gene expression directly ex vivo
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Summary We report on a new methodology which allows the direct analysis ex vivo of tumour cells and host
cells (lymphocytes, macrophages, endothelial cells) from a metastasised organ (liver or spleen) at any time point
during the metastatic process and without any further in vitro culture. First, we used a tumour cell line
transduced with the bacterial gene lacZ, which permits the detection of the procaryotic enzyme ,B-galactosidase
in eukaryotic cells at the single cell level thus allowing flow adhesion cell sorting (FACS) analysis of tumour
cells from metastasised target organs. Second, we established a method for the separation and enrichment of
tumour and host cells from target organs of metastasis with a high viability and reproducibility. As exemplified
with the murine lymphoma ESb, this new methodology permits the study of molecules of importance for
metastasis or anti-tumour immunity (adhesion, costimulatory and cytotoxic molecules, cytokines, etc.) at the
RNA or protein level in tumour and host cells during the whole process of metastasis. This novel approach
may open new possibilities of developing strategies for intervention in tumour progression, since it allows the
determination of the optimal window in time for successful treatments. The possibility of direct analysis of
tumour and host cell properties also provides a new method for the evaluation of the effects of immunisation
with tumour vaccines or of gene therapy.
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The interaction between tumour and host cells determines to
a large extent the outcome, namely tumour growth and
progression towards metastases or tumour arrest, dormancy
or rejection. Most of the studies published so far on
interactions of tumour cells and host cells were made in
vitro and dealt with aspects such as cell adhesion,
proliferation, invasiveness, cytotoxicity or cytokine produc-
tion. Since the microenvironment in tissue culture differs in
many respects from that in vivo, new approaches for in vivo
studies of tumour -host cell interactions are of utmost
importance in cancer research.
To elucidate the metastatic phenotype, approaches have
been made to relate, for instance, cell surface molecules
expressed on the tumour cell lines from tissue culture to their
propensity to generate metastases in vivo (Nicolson 1982,
1987). Several authors have reported that certain steps of the
metastatic cascade are rate limiting (Hart et al., 1989; Fidler,
1990; Fidler and Radinski, 1990; Kerbel, 1990; Fodstad,
1993). To produce metastases, tumour cells must complete
each of the sequential steps in the pathogenesis of cancer
metastasis. Each discrete step appears to depend on the
interaction between tumour cells and multiple host factors
(i.e. the microenvironment of the tumour) and to be regulated
by transient or permanent changes in DNA, RNA or proteins
of multiple genes. Against this background, the need for
comprehensive in vivo/ex vivo studies on tumour -host
interactions and their kinetics in relevant model systems
becomes obvious.
We have established a new method allowing the ex vivo
isolation of tumour and host cells (tumour microenviron-
ment) at any time point during the metastatic process and
without any further in vitro culture. We chose as a model the
ESbL lymphoma, transduced with the lacZ gene. This allows
the detection of tumour cells at the single cell level either in
frozen sections from target organs (liver, spleen, etc.) by
staining with 5-bromo-4-cloro-3 indoyl-fl-D-galactopyrano-
side (X-Gal) or as live cells after tissue dissociation staining
with fluorescein-di-fl-galactopyranoside (FDG) (Kruiger et al.,
1994a). In this ESbL-lacZ tumour model, intradermal tumour
growth and liver metastasis development followed three
distinct phases: a first exponential growth phase, a transient
plateau phase and a second expansion phase. The plateau
phase was characterised by a constant tumour diameter,
correlating with a constant low amount of metastasis in the
liver. This phase was followed by an aggressive second
expansion phase leading to macroscopic metastases in
multiple visceral organs and to death of the animals within
a few days (Kruger et al., 1994b). These different phases of
the metastatic process provide a good model for the
investigation of the influence of tumour-host interactions
during metastasis and of ways of modulating it. The plateau
phase allows the study of the mechanisms of immunoresis-
tance and tumour control. The second tumour expansion
phase allows the study of the mechanisms of breakdown of
immunoresistance and perhaps molecules of importance in
metastatic progression.
Materials and methods
Mice, cell lines and cell injections
DBA/2 mice were obtained from Iffa Credo (Lyon, France)
and used at 6-12 weeks of age. lacZ-transduced ESbL cells
(clone L-CI.5s) were cultured as described (Kruger et al.,
1994a). Cells were washed in phosphate-buffered saline (PBS)
and adjusted to the appropriate concentration. For standard
intradermal injection, 2 x 105 cells were injected into the
animal's cutis at the shaved flank of anaesthetised [Rompun
(0.1%)-Ketanest (0.25%)-PBS diluted 1:1:3 (vol)] ani-
mals.
Isolation of tumour and sinusoidal cells from metastatic livers
Cell isolation was performed as described (Rocha et al.,
1996). Briefly, livers from anaesthetised tumour-bearing mice
were washed in situ by perfusion through the portal vein at
37°C with 10 ml a modified Eagle medium (MEM) contain-
ing 15 mM Hepes at a flow rate of 3 ml min-'. Tissue
digestion was carried out during perfusion with 10 ml of x-
MEM/Hepes containing 0.05% pronase E (Boehringer
Mannheim, Germany) at 1 ml min-' and then with 15 ml
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of the same medium containing 0.03% pronase E, collagenase
A (from Clostridium hystolyticum, Boehringer Mannheim).
After perfusion, livers were minced and stirred in 13 ml a-
MEM/Hepes containing 0.04% pronase E, 0.04% collagenase
and 0.0004% DNAase (Sigma Chemical Co., USA) at 37°C
for 10 min. The cell suspension was then filtered through a
nylon gauze and centrifuged at 300 g for 10 min. To remove
cell debris and erythrocytes, the cell pellet was centrifuged at
1400 g for 15 min in oa-MEM/Hepes containing 17.5% (w/v)
metrizamide (Sigma Chemical Co.), followed by washing of
the top layer with ax-MEM/Hepes at 300 g for 10 min.
Antibody staining of tumour and sinusoidal cells
About 1 x 106 cells were washed in PBS buffer supplemented
with 5% fetal calf serum (FCS) and incubated at 4°C for
10 min with first antibodies. The following rat anti-mouse
monoclonal antibodies were used as culture supernatants:
anti-CD4 (clone GK 1.5); E-selectin (clone 21KC1O), specific
for endothelial cells; and anti-macrophage antibody (F4/80).
After washing, cells were incubated with the second antibody
(F(ab')2 goat anti-rat, mouse Ig absorbed, R-phycoerythrin
conjugated, Gibco BRL). Control cells were incubated with
FACS buffer instead of the antibody, before staining with the
second antibody.
FDG staining and FACS analysis of tumour and host cells
After antibody staining, sinusoidal cells were washed in PBS
supplemented with 5% FCS and incubated in 100 ml PBS/FCS
at 37°C for 10 min. Quantification of liver metastases was
performed at the single cell level by loading and staining with
FDG (fluorescein-di-fl-D-galactopyranoside) as described
(Kruger et al., 1994b). Cells were loaded by hypotonic shock
with 100 ml of prewarmed FDG (Molecular Probes, Inc.,
Eugene, OR, USA) in water, mixed, vortexed and incubated for
1 min at 37°C. Ice-cold 5% FCS/PBS (1.8 ml) was then added,
the cells were kept for 10 min on ice and treated for 5 min
before analysis with 1.5 gM propidium iodide (final concentra-
tion). Flow adhesion cell sorting (FACS) analysis was
performed using a FACScan (Becton-Dickinson). About
30 000 cells per sample were simultaneously measured for
FSC and integrated side scatter (SSC) as well as green (FLI)
and red (FL2 and FL3) fluorescences (expressed as logarithm of
the integrated fluorescence light). Recordings were made only
on propidium iodide-negative (viable) cells of the red (FL3)
fluorescence, excluding aggregates whose FSCs were out of
range. Ex vivo expression ofcell surface molecules was analysed
by histograms ofred fluorescence (FL2) distribution plotted as
number ofcells (y-axis) vs fluorescence intensity (x-axis) for the
different tumour and sinusoidal cell populations.
Isolation of liver endothelial cells
After isolation of liver sinusoidal and tumour cells, they were
cultured on type 1 collagen-coated plastic Petri dishes in a-
MEM supplemented with 10% FCS at 37°C in an incubator
under 5% carbon dioxide/air. Two hours later supernatants
werecollected and adherentcells (endothelialcells) werescraped
offwith arubberspatula,counted, pelleted, snapfrozeninliquid
nitrogen and kept at - 70°C for RNA studies. The same
procedure was used for isolation of endothelial cells from
normal (non-tumour-bearing) mice. Purity of endothelial cell
populations was evaluated as described (Rocha et al., 1995).
Isolation of Kupifer cells from metastatic livers
Kupffer cells were isolated after differential adhesion from the
collected supernatants. Plastic culture dishes (Greiner,
Germany) were treated with 2.5% glutaraldehyde (Merck,
Germany) in PBS for 2 h at 4°C followed by washing 10
times in PBS and incubation of isolated sinusoidal cells for
30 min at 37°C in 5% carbon dioxide. The adherent cells
were removed with a rubber spatula, counted, pelleted, snap
frozen in liquid nitrogen and kept at - 700C for RNA
studies. Purity of Kupffer cell population was evaluated as
described (Umansky et al., 1995).
Isolation of lymphocytes and tumour cellsfrom metastatic
livers
Separation of tumour cells from lymphoid cells was
performed by FDG staining and flow cytometry cell
sorting. FDG staining was performed as described (Kruger
et al., 1994b). About 5 x 106 cells per sample of isolated
tumour and lymphoid cells which remained after the two
adhesion steps described above, were washed in PBS with
FCS and incubated at 37°C for 10 min. Then, 100 ml of
prewarmed FDG (Molecular Probes, Eugene, OR, USA) in
water were added to the cell suspension and incubated for
4 min at 37°C (hypotonic shock). Cold 5% FCS/PBS
(1.8 ml) was then added, the cells kept for 10 min on ice
and stained with 1.5 gM propidium iodide (final concentra-
tion). Sorting was performed using a FACS Vantage sorter
(Becton-Dickinson, Heidelberg, Germany). A window for
sorting was defined in the FDG-positive cells (tumour cells)
excluding dead cells and debris with propidium iodide. Flow
rate was 3000-5000 cells s-' and sorted cells were collected
in sterile tubes containing RPMI with 20% FCS. After
centrifugation of the total collected fractions, tumour cells
and lymphocytes, pellets were snap frozen in liquid nitrogen
and kept at -70°C until use for RNA extraction.
RNA extraction, hybridisation and densitometric quantitation
Cell pellets were homogenised with 0.2 ml of RNA-Clean
(Angewandte Gentechnologie Systeme, Heidelberg, Ger-
many) per 2 x 106 cells and RNA extraction performed by
the chloroform/phenol technique-. Extracted RNA was
precipitated with isopropanol, the pellet washed in ethanol,
dried under vacuum and resuspended in DEPC treated
water. Quantity of RNA was measured by absorbance at
260 nm. Total isolated RNA was denatured and spotted
onto a nitrocellulose filter using a dot blot apparatus and
fixed by UV cross-linking with vacuum (Heraeus). Mem-
branes were prehybridised for 2 h at 42°C in solution
containing 1% formamide, 20 x saline sodium citrate (SSC)
and 1% sodium dodecyl sulphate (SDS). Hybridisation was
performed in the same solution for 24-48 h at 42°C with
the cDNA probes. The following cDNA probes were used
for hybridisation: MHC class II, a and # chain (kindly
provided by Dr F Momburg), ICAM-1 and integrin a4
chain (kindly provided by Dr P Altevogt). cDNA inserts
were labelled with 32p to a specific activity of about 2 x 108
c.p.m. per jMg DNA by oligolabelling kit (Pharmacia,
Sweden). After hybridisation, filters were washed three
times for 30 min with SSC and SDS at 68°C. Membranes
were exposed to 0-MAT films (Kodak, Germany) at
-70°C. Expression of the mRNA was quantified by
densitometry of autoradiograms using the Adobe Photoscop
Program and the SCAN analysis program from Macintosh
with each sample measurement calculated from the ratio of
the average areas between the specific mRNA transcripts
and the f,-actin mRNA transcripts.
Results
Identification and analysis of ex vivo isolated tumour and
sinusoidal cells during Iymphoma metastasis by flow cytometry
The number of sinusoidal cells obtained per mouse liver was
5-8 x 106 depending on factors such as age and weight of
the mice and size of the liver. In the case of metastatic
livers, the total amount of sinusoidal and tumour cells was
20-25 x 106 per mouse. Viability was higher than 93% in
both cases. After antibody incubation and FDG staining, we
analysed tumour cells and sinusoidal cells by flow cytometry.
Figure 1 shows the analysis of sinusoidal and tumour cells
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isolated from metastatic livers at day 28 after tumour
injection. At this time point the percentage of tumour cells
in the liver is 40-50% of the total sinusoidal cell population
(Kruger et al., 1994b). Contour plots of the total population
were analysed following loading and staining with FDG.
Tumour cells were identified as green fluorescence-positive
cells (R2) and compared with the non-fluorescent cells,
which represent the sinusoidal cell population (RI). Different
sinusoidal cell populations were identified as previously
described (Rocha et al., 1995) and gated for separate
analysis. Further characterisation of the gated populations
was achieved by cell surface staining with rat monoclonal
antibodies (MAbs) and dye-labelled secondary anti-rat Ig
reagents. As can be seen from the profiles in Figure 1, CD4
was positive in the first region (lymphoid cells), E-selectin in
the second region (endothelial cells) and F4/80 in the third
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region (Kupffer cells). Tumour cells could be easily
distinguished as FDG-positive cells (Figure 1), although
the hypotonic shock treatment also slightly changed the
profiles of the normal cell populations. Combining FDG
staining of tumour cells and MAb staining, we recently
demonstrated up-regulation of the expression of surface
molecules, such as LFA-1 and ICAM-1, on liver metastases.
Further antibody blocking experiments suggested that these
adhesion molecules were of importance for metastatic
expansion in the liver (Rocha et al., 1996).
Isolation and enrichment of tumour and host cell populations
from metastatic organsfor studies at the transcriptional level
After in vivo liver perfusion and metrizamide gradient
centrifugation, the isolated total sinusoidal cell population
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Figure 1 Flow cytometric analysis of ex vivo isolated cells from a metastasised liver, 28 days after intradermal transplantation of
ESbl-lacZ lymphoma cells. a and b, Contour plots of forward scatter vs green fluorescence (FL1) of isolated cells without (a) or
with (b) FDG loading. Tumour cells were identified in b as green fluorescence-positive cells (R2) and compared with normal host
sinusoidal cells (R1). R3 represents the total population. c, Two-parameter slice plots of forward side scatter of the sinusoidal
population from b. R4 represents lymphocytes, R5, endothelial cells and R6, Kupffer cells. Identity of the gated populations, R4-
R6, is shown by the FACS profiles below after indirect immunofluorescence staining with CD4 (positive in R4, lymphoid cells), E-
selectin (positive in R5, endothelial cells) and F4/80 (positive in R6, Kupffer cells). Tumour cells were identified as fluorescence
positive after hypotonic loading with FDG. Controls included cells with or without FDG loading or with and without first
antibody. In each column, the left histogram represents the non-specific binding of PE-conjugated second antibody and the right
histogram the specific binding of the indicated MAb to the same cells. When two histograms match, specific binding is negligible or
absent. Numbers indicate the percentage of positive cells with the respective antibodies.Ex vivo analysis of tumour and host cells during lymphoma
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was subfractionated into different populations. The percen-
tage recovery of cells at the end of the whole procedure was
50-60%. First, cells were plated on collagen-pretreated
dishes to separate adherent endothelial cells. Two hours
was found to be the optimum culture time in terms of
viability, purity and yield of endothelial cells. The number of
cells obtained was approximately 25-35% of the total seeded
population (Figure 2). The non-adherent cells were removed
and seeded over glutaraldehyde-pretreated dishes, which has
been described as being an effective method to obtain Kupffer
cells with a high purity (Smedsrod et al., 1985). Since the
viability of the separated population decreased dramatically
with time in culture, we decided that 30 min was the optimal
time in terms of cell yield and viability. The number of
Kupffer cells obtained was between 35% and 40% of the
total seeded population (Figure 2). Both endothelial and
Kupffer cell fractions were scraped off with a rubber
policeman, pelleted and snap frozen to avoid RNA
destruction by RNAases (Figure 2).
The remaining non-adherent cell suspension was a mix of
lymphocytes and lacZ-tagged tumour cells. FDG loading ofthe
cell suspension and FACS cell separation was performed as
described in Materials and methods. At day 28 after
intradermal ESbL-IacZ tumour cell inoculation, the number
of tumour cells in the liver approximated 15 -25% ofthe total
population and that ofthe lymphocytes about 10 - 15% (Figure
2).
As a second metastasised organ we investigated the spleen.
Spleen macrophages were isolated from the single cell
suspension by plastic adherence. The remaining super-
natant, containing lymphocytes and tumour cells, was
stained with FDG and sorted as described above.
Figure 3 shows examples of the analysis of gene expression
of different cellular subpopulations isolated from metastatic
spleens or livers. Lymphocytes isolated from control spleens
and from metastatic spleens at the plateau phase (day 16) and
at the end of the metastatic process (day 28) showed
differences at the RNA level with regard to expression of
distinct molecules, such as MHC class II a chain (Figure 3a
and b). The signal obtained with MHC class II a chain
cDNA or other probes was compared with f,-actin as internal
standard and transformed into expression units. Lympho-
cytes at day 28 of the metastatic process (column 3) expressed
only 46% of the as chain in comparison with lymphocytes
from normal control mice (column 1). Spleen macrophages
isolated at day 28 (row 4) expressed 80% class II a chain in
comparison with controls (column 2). Column 5 shows the
expression of MHC class II a chain in splenic lymphocytes
and macrophages together from day 28 metastasised organs
and column 6 represents the expression of class II a chain by
the sorted tumour cells.
Liver endothelial cells were isolated from metastatic livers
at day 16 or day 28 after tumour cell inoculation. The
expression of different RNA molecules was compared with
cells from two different experiments and time points (day 16,
columns 8 and 9; day 28, column 10). As shown in Figure 3c
and d, expression of ICAM-1 was down-regulated at day 16
in both experiments (40% and 35% respectively) and less so
at day 28, compared with the control. This differential
expression if ICAM-1 in endothelial cells isolated from
metastatic livers at different time points has been observed
previously also at the protein level (Rocha et al., 1996).
Analysis of Kupffer cells (Figure 3e and f), isolated at the
same time points (day 16 and 28) showed no significant
changes in the expression of ICAM-1 molecules. The study of
the expression of MHC class II molecules (fl-chain) in
Kupffer cells from day 16 (columns 12 and 13) and day 29
(columns 14 and 15) compared with the control (column 11)
showed that there was a slight up-regulation of expression of
this molecule at day 16 after tumour injection.
Isolated tumour cells were studied for the expression of
different molecules potentially involved in metastasis
formation. We found differences, as shown in Figure 3g
and h, in expression of VLA-4 RNA in tumour cells from
tissue culture (column 17) and that of tumour cells from day
16 (column 18) or day 28 (column 19). Results show that
the expression of VLA-4 is down-regulated in tumour cells
in vivo at both time points. To prove that the FDG
technique did not miss some in vivo revertant tumour cells,
we performed a control experiment as follows: we isolated
host and tumour cells from metastatic livers at day 28, when
tumour load is 50% of the total population. After long-term
culture only tumour cells should survive. Therefore, if the in
vivo isolated cells kept the lacZ gene, all the remaining
tumour cells in the culture should have it, since it is
genetically transferred. If after this time in culture we found
FDG-negative cells, it would mean that some of these
tumour cells lost the lacZ gene during in vivo development.
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FDG staining after one culture showed that 99.5% of the
cells were FDG-positive cells and no revertant cells were
missed by the FDG technique.
In conclusion, our method provides a new tool to study
expression changes at the RNA and protein level of
molecules potentially involved in metastasis progression or
inhibition.
Discussion
Organotropism, i.e. the preference of certain cancers to
metastasise to certain organs and tissue-specific metastasis
patterns are quite often seen in clinic samples and in
experimental tumour models. Both phenomena underline
the importance of local microenvironmental factors for the
development of metastases (Fidler, 1986; Liotta, 1986;
Hoffman, 1992). Several studies correlated phenotypic
features of tumour cells before being injected into animals
with the final outcome of metastasis and formed the basis for
terms such as the 'metastatic phenotype' (Kerbel 1990; Fidler,
1990). Also, in recent years the concept of 'dynamic
heterogeneity' was introduced. It suggests that the metastatic
phenotype, although it is a genetically controlled trait, is
inherently dynamic or unstable (Weiss et al., 1980; Ling et
al., 1985; Vaage, 1988). Because of this phenotypic instability,
an adequate methodology has to be established for direct
typing of tumour cells at distinct stages of the metastatic
process without in vitro culture.
We have established a new methodology for the study of
tumour-host interactions in the metastatic process. Firstly,
we used a tumour cell line transduced with the bacterial gene
lacZ, to study tumour-host interactions, for instance during
micrometastasis, minimal residual disease or tumour dor-
mancy. Secondly, we have established a method allowing the
separation of tumour and host cells from the liver and spleen
with a high viability (93-95%) and reproducibility which can
be used for different target organs. This permits the direct
characterisation of ex vivo isolated cells without further in
vitro culture. Control experiments in reisolated and cultured
tumour cells showed that the FDG technique is very specific
and sensitive, since all the tumour cells express the lacZ gene
after being grown in vivo. This excludes the possibility of the
existence of lacZ-revertant tumour cells which could not be
detected and quantified as tumour cells.
The described technique provides the possibility of
studying molecules involved in the metastatic process at
two different levels, mRNA and protein (for instance,
adhesion molecules, homing receptors, immune stimulatory
molecules, etc.). Malignant cells disseminate from a locally
growing tumour to other sites by means of adhesion
molecules (e.g. LFA-1, ICAM-1, VLA-4) and homing
receptor molecules (e.g. MEL-14) which are used by
haemopoietic normal cells for traffic and localisation in
various organs or at sites of inflammation. It has been
suggested, for example, that the adhesion of melanoma cells
to activated endothelium is mediated by VLA-4 receptors,
thus implicating this adhesion molecule in metastatic process
(Garofalo et al., 1995). Our results, however, showed that the
VLA-4 molecule was down-regulated in the ESbL-lacZ
tumour cells when injected into syngeneic animals. Evidence
that LFA-1 and ICAM-1 are involved in metastatis has also
been presented (Zalhaka et al., 1993; Harning et al., 1993). In
support of these observations, we have recently shown by
using this new methodology that the expression of LFA-1
and ICAM-1 molecules was up-regulated during the
progressive phase of tumour growth and metastasis in the
ESbL-lacZ lymphoma model (Rocha et al., 1996). Conse-
quently, a strategy was developed to apply antibodies against
these adhesion molecules before the final progressive phase of
tumour growth started. Such experiments resulted in
complete inhibition of tumour progression in vivo (Rocha et
al., 1996).
The results from Figure 3 show that the expression of
adhesion molecules such as ICAM-1 in endothelial cells or
VLA-4 in metastasising tumour cells is regulated in vivo at
the RNA level. This method of analysis may thus provide a
possibility of determining which molecules and which window
in time may be suited for therapeutical intervention.
Other molecules such as costimulatory molecules, MHC
class I or class II and CD80 (B7-1), which have been reported
to be important in the recognition of the tumour cells by the
immune system (Becker et al., 1993; Chen et al., 1992), can
also be studied by this method during the whole process of
tumour growth and metastasis. The observed down-regula-
tion of MHC class II RNA in lymphocytes from metastatic
spleens at a late stage of metastasis could lead to a decrease
of recognition of tumour-associated antigens on tumour cells,
hampering an effective immune response.
Northern and slot blot techniques allowed the study of
molecules of importance in metastasis. There have been
numerous reports showing that the metastatic potential of
tumours may correlate directly with the expression level of
distinct genes. Some genes coded for adhesion and
costimulatory molecules (Becker et al., 1993; Chen et al.,
1992), others for growth factors, growth factor receptors,
enzymes or multidrug resistance (bFGF, EGFR, type IV
collagenase or mdr-1) (Fidler, 1995). In this study, the
differential expression of genes coding for VLA-4, ICAM-1
and MHC class II on tumour and host cells was closely
associated with metastatic progression or growth retardation.
The technique provides new possibilities of using ex vivo
isolated cells for different purposes. Ex vivo isolated
metastasised tumour cells can be used for cell-cell
interaction studies with different host cells, for investigation
of cytokine and growth factor production and as target cells
in cytotoxicity assays with ex vivo isolated lymphocytes or
macrophages. Endothelial and Kupffer cells provide a tool
for adhesion studies with tumour cells (Asumendi et al., 1996)
and for evaluation of the production of different cytokines
and cytotoxic molecules. One example ofcytotoxic substances
produced by activated host cells is nitric oxide (NO) (Rocha
et al., 1995; Umansky et al., 1995). NO has been identified
recently as an effector molecule of cytotoxicity mediated by
macrophages and endothelial cells (Hibbs et al., 1988). Its
toxic effect is a result of inhibition of DNA synthesis and of
Figure 3 Slot blot analysis of gene expression of different cellular subpopulations isolated from metastatic spleens or livers of Esb-
lacZ tumour bearing mice. Organs were removed from either normal mice (control) or from tumour-bearing mice 16 days or 28 days
after intradermal tumour cell transplantation. Tumour and host cells were separated and total RNA prepared as described in Figure
2. The different RNAs were blotted onto nitrocellulose and hybridised with test probes for MHC class II a chain (a), ICAM-1 (c),
MHC class II ,B chain (e), VLA-4 (a4) (left panels) or with a ,B-actin probe as internal control (right panels in a, c, e and g. The slot
blots are shown in a, c, e and g and the corresponding histograms of gene expression in b, d, f and h. Values in the histograms were
obtained as follows: levels ofmRNA expression were measured by densitometry and the ratio of densities between the expression of
each test molecule and its corresponding f,-actin control was determined. For every test probe the maximum value was considered as
100 units to which the other values were related. We evaluated mRNA transcripts in host and tumour cells separated from two
independent experiments. Since results were comparable, we give the results of one experiment. *indicates significant differences in
comparison with respective controls (P<0.05). In b, lym, lymphocytes; mac, macrophages; host cells, total spleen cells (day 28) and
tumour cells, spleen-metastasised tumour cells (day 28). In f, KC, Kupffer cells. In h, gene expression in control tumour cells from
tissue culture is compared with that of tumour cells (TC) from metastasised livers (day 16 and 28).,~~~~Ex Etomo di ofV cf and Mdcat
ci- _i-ic a
%O M Rodha et al
1222
mitochondrial respiration in tumour target cells (Moncada et
al., 1991). Lymphocytes can be used to investigate cytokine
production, in proliferation assays and as a tool for different
therapeutical interventions.
In conclusion, we should like to point out the potential of
this methodology. It allows the direct ex vivo analysis ofgene
expression (RNA or protein) in tumour and host cells at
every time point during tumour growth and metastasis. This
experimental approach opens a broad possibility for studies
of the basic mechanisms of tumour development, for
example: (1) evaluation of vaccination effects in target
organs; (2) determination of the right window in time for
cancer therapy; and (3) investigation of the effects of
transferred immune cells, tissues or organs on the host, for
instane in the processes of graft vs leukaemia and graft vs
host disease (Schirrmacher et al., 1995). Work is now in
progress on the establishment of methods allowing the
separation of host and tumour cells from human primary
tumours and metastasis.
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